Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Anticandidal activity of synthetic peptides: Mechanism of action revealed by scanning electron and fluorescence microscopies and synergism effect with nystatin

Full text
Author(s):
Lima, Patricia G. [1] ; Souza, Pedro F. N. [1] ; Freitas, Cleverson D. T. [1] ; Oliveira, Jose T. A. [1] ; Dias, Lucas P. [1] ; Neto, Joao X. S. [1] ; Vasconcelos, Ilka M. [1] ; Lopes, Jose L. S. [2] ; Sousa, Daniele O. B. [1]
Total Authors: 9
Affiliation:
[1] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara - Brazil
[2] Univ Sao Paulo, Dept Appl Phys, Sao Paulo - Brazil
Total Affiliations: 2
Document type: Journal article
Source: JOURNAL OF PEPTIDE SCIENCE; v. 26, n. 6 MAR 2020.
Web of Science Citations: 0
Abstract

Candida albicans has emerged as a major public health problem in recent decades. The most important contributing factor is the rapid increase in resistance to conventional drugs worldwide. Synthetic antimicrobial peptides (SAMPs) have attracted substantial attention as alternatives and/or adjuvants in therapeutic treatments due to their strong activity at low concentrations without apparent toxicity. Here, two SAMPs, named Mo-CBP3-PepI (CPAIQRCC) and Mo-CBP3-PepII (NIQPPCRCC), are described, bioinspired by Mo-CBP3, which is an antifungal chitin-binding protein from Moringa oleifera seeds. Furthermore, the mechanism of anticandidal activity was evaluated as well as their synergistic effects with nystatin. Both peptides induced the production of reactive oxygen species (ROS), cell wall degradation, and large pores in the C. albicans cell membrane. In addition, the peptides exhibited high potential as adjuvants because of their synergistic effects, by increasing almost 50-fold the anticandidal activity of the conventional antifungal drug nystatin. These peptides have excellent potential as new drugs and/or adjuvants to conventional drugs for treatment of clinical infections caused by C. albicans. (AU)

FAPESP's process: 18/19546-7 - Molecular mechanisms of the binding, insertion, and orientation of antimicrobial peptides in model membranes
Grantee:Jose Luiz de Souza Lopes
Support Opportunities: Regular Research Grants